Photodynamic therapy: A novel approach to treat variety of diseases

Indian Drugs

Volumn 33, Issue 10, 1996, Pages 487-495

  Kulkarni, S R ^a   Korgaonkar, C K ^b  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; LOW DENSITY LIPOPROTEIN; MEROCYANINE; PHOTOSENSITIZING AGENT;

ATHEROSCLEROSIS; CANCER; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; MEMBRANE BINDING; NONHUMAN; PHOTODYNAMIC THERAPY; PSORIASIS; RETINA MACULA DEGENERATION; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS INFECTION;

EID: 0029848199     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Foote, C.S. Chemical mechanisms of photodynamic action. Proc SPIE Institute, Advanced Optical Technologies of Photodynamic Therapy IS, 1990, 6, 115-126.
2. Marks, G S, Chemical, Biochemical and Medical aspects" in Heme and chlorophyll Ed. Marks. G S. Ed. D. Van. Nostrand Company Ltd., 1969, 95.
3. Dall Acqua, F., Jori, G. Photochemotherapy in Principles of Medicinal Chemistry, Foye, W., ed., Vargehese Publishing House., 1989, 803-816.
4. Bellnier, D.A., and Dougherty T.J., Membrane lysis in Chinese hamster ovary cells treated with hematoporphyrin derivative plus light. Photochem. Photobiol., 1982, 36, 43-47.
5. Auler, H., and Banzer, G., Untersuchungen uber die rolle der porphyrine be gschwaarlstkranken mnscheen and tiern. Z. kreebsforsch, 53, 65-68, 1943. (c.f. Moan, J., and Berg, K. Photochemotherapy of Cancer : Experimental Research, Photochem. and Photobiol., 1992, 55, 931.
6. Auler, H., and Banzer, G., Untersuchungen uber die rolle der porphyrine be gschwaarlstkranken mnscheen and tiern. Z. kreebsforsch, 53, 65-68, 1943. (c.f. Moan, J., and Berg, K. Photochemotherapy of Cancer : Experimental Research, Photochem. and Photobiol., 1992, 55, 931.
7. Oenbrink, G., Jurgenlimke, P, and Gabel, D., Accumulation of porphyrins in cells : influence of hydrophobicity, aggregation, and protein binding, Photochem. Photobiol., 1988, 48, 451.
8. Moan J., and Sommer, S., Uptake of the components of hematoporphyrin derivative by cells and tumors. Cancer Lett., 1984, 24, 291.
9. Jori, G., Beltramini, M., Reddi, E., Salvato, B., Pagnan, A., Ziron, L., Tomio, L. and Tsanov, T., Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo, Cancer Lett., 1983, 21, 167
10. Brault, D., Physical chemistry of porphyrins and their interaction with membranes : the importance of pH. J. Photochem. Photobiol., 1990, 6, 79-86.
11. Brown, M.S, and Godstein, JL. Receptor mediated control of cholesterol metabolism. Science, 1976, 191, 150-154
12. Moan J., Berg, K., Photochemotherapy of cancer : Experimental Research Photochem and Photobiol., 1992, 55(6) 931-948.
13. Dougherty, T.J., Potter, W.R., Bellnier, D., Photodynamic therapy for the treatment of cancer current status and advances, in Photodynamic Therapy of Neoplastic Diseases Kessel, D, Ed., CRC press, Boca Raton, 1988, vol I, 1-8.
14. Dougherty, T J., Photosensitizers. Therapy and detection of malignant tumors. Photochem. and Photobiol., 1987, 45(6), 879-889.
15. Chan W.S., Marshall, J.F., Lam, Y.F. Tissue uptake and distribution and potency of the photoactivatable dye chloroaluminum sulfonated phathalocyanine in mice bearing transplantable tumors, Cancer Res., 1988, 48, 3040-3044.
16. Dougherty, T.J., Pottes, W.R., and Weishaupt, K.R. The structure of the active component of hematoporphyrin derivative, in Porphyrin Localization and Treatment of Tumors, Doiron, D.R., Gomer C J , Alan R. Liss Inc., Ny., 1984, 301-314.
17. Dougherty, T J., Photodynamic Therapy : Recentachievements, Photochem. Photobiol., 1987, 46, 837-841.
18. Levy, J., "Light activated drugs in the treatment of disease." Pharmaceutical Manufacturing International p39, 1994.
19. Chen, L.B., Mitochondrial membrane potential in living cells, Annu. Rev. Cell Biol., 1988, 4, 155.
20. Davis, S., Weiss, M.J., Wong, J.R., Lampidis, T.J., and Chen, L.B., Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells, J. Biol. Chem., 1985, 260, 13844.
21. Emaus, R.K., Grunwald, R., and Lemasters, J.J., Rhodamine 123 as a probe of transmembrane potential in isolated rat liver mitochondria: spectral and metabolic properties, Biochem. Biophys. Acta., 1986, 850, 436.
22. Modica Napolitono, J.S. and Aprille, J.R., Basis for the selective cytotoxicity of rhodamine 123, Cancer Res , 47
23. Chen, L.B., Flourescent labelling of mitochondria, Methods Cell Biol., 1989, 29, 103
24. Ara, G., Dahl, T , Wadwa, K.S. and Oserott, A.R., Cationic photosensitizers and light cause single strand breaks in closed-circular plasmid DNA, Annu. Meet. Am. Assoc Cancer Res , 1989, 30, 2.
25. Kim, S.H., Kim J.H , Hahn, E.W., and Ensign, N.A , Selectively killing of glucose of oxygen deprived HeLa cells by hyperthermia, Cancer Res., 1980, 40, 349.
26. Grweck, L.E., Dahlberg, W.K., Epstein, L.F , and Shim, D.S., Influnce of nutrient and energy depriving on cellular response to single and fractionated heat treatments, Radiat. Res., 1984, 99, 573.
27. Ara, G., Aprille, J.R., Foley, J., Cincotta, L., and Oseroff, A.R., A. kryptocyanine dye causes photosensitized site specific inhibition of mitochondrial electron transport and alters ATP levels and cell cycle distributions, Photochem. Photobiol., 1986, 43 (suppl.), 49s
28. Bernal, S.D., Lampidis, T.J., McIssac, R.M. and Chen, L.B., Antcarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye, Science, 1983, 222, 169.
29. Mew, D., Lum, v., Wat, C.K., Towers, G.H N., Sun, C.H.C., Walter, R.J., Wright, W., Berns, M.W., and Levy. J.G., Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cells lines subsequent to light activation, Cancer Res., 1985, 45, 4380.
30. Oseroff, A.R., Ara, G., Ohuho, D., Aprille, J., Bommer, J.C., Yarmush, M.L., Foly, J., and Cinetto, L., Strategies for selective cancer photochemotherapy : antibody targeted and selective carcinoma cell photolysis. Photochem. Photobiol., 1987, 46, 83.
31. Jori, G., Pharmacokinetic studies with hematopodrphyrin in tumor bearing mice in Photodynamic Therapy of tumors and other diseases, Jori, G. and Perria, C.A., Eds., Libreria Progetto. Padua, 1984, 159.
32. Barel, A., Jori, G , Perin, A., Romandini, P., Pagnan A., and Biffani, S., Role of high-, low and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo, Cancer Lett., 1986, 32, 1455
33. Jori, G., Cozzani, I., Reddi, E., Rossi, E., and Tomio, L., In vitro and in vivo studies on the interaction of hematoporphyrin and its dimethylester with normal and malignant cells, in Porphydrin Localization and Treatment of Tumors, Doiron, D.R. and Gomer, C J., Eds. Alan R. Liss, New York, 1984, 471.
34. Reddi, E., Lo castro, G , Biolo, R., and Jori, G., Pharmacokinetic studies with Zn(II) phthalocyanine in tumor bearing mice Br. J. Cancer., 1987, 56, 597.
35. Berns, M.W., Rettenmaier, M.A., McCullough, J.L , Coffey, J., Wile, A.G , Berman, M.L., Disaia, P.J., and Weinstein, G.D , Responses of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative, Lasers Surg. Med., 1984, 4, 73.
36. Murphy-chutorian D., Kosek, J., Mok, W., Quay S., Hustis, W , Mehilgan, J , Profit, D , and Ginsburg, R , Selective absorption of ultraviolet laser energy by atherosclerotic plaque treated with tetracycline Am. J. Cardiol., 1985, 55, 1293.
37. Pagnan, A., Scannapico, G., Pauletto, P., Jori, G., Mattiello, A., Perin, A., Romandini, P., and Dalpalu, C., Hematoporphyrin retention by atherosclerotic plaques in the broad breasted white-turkey-studies on the distribution and quantitation in the aortic tissue and on uptake by cultured aortic smooth muscle cells in Recent Aspect of Diagnosis and Treatment of Lipoprotein Disorders. Impact on Prevention of Atherosclerotic Diseases, Widhaln, K. and Naito, H.K., Eds., Alan R. Liss, New York., 1988, 135.
38. Thomas, E.L. and Langhofer, M., Closure of experimental subretinal neovascular vessels with dihematoporphyrin ether augmented argon green laser photocoagulation. Photochem. Photobiol., 1987, 46, 881.
39. Siber, F., O'Brien, J., M., Krenger, G., J., Schober, S.L., Burns, W.H., and Sensenbrener, L.L., Antiviral activity of merocyanine 540, Photochem. Photobiol., 1986, 46, 707.
40. Matthews, J.L., Newman, J.J., Sogandars-Bernal, F., Judy, M.M., Skiles, H., Leve son, J.E., Marengo-Rowe, A.J., and Chanh, T.C., Photodynamic Therapy of viral contaminants with potential for blood banking applications, Tranfusion., 1987, 28, 81
41. Melnick, J L and Wallis, C., Photodynamic inactivation of herpes virus, in The science of Photomedicine, Regan J D. and Parrish, J.A , Eds., Plenum Press, New York, 1982, 571.